Oncternal Therapeutics Inc. (ONCT) reported Q4 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $171 thousand versus the consensus estimate of $306.2 thousand.
Oncternal Therapeutics Inc. (ONCT) reported Q4 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $171 thousand versus the consensus estimate of $306.2 thousand.